News Releases

For immediate release

CODEBASE VENTURES INC. PROVIDES UPDATE ON WORLD HIGH LIFE INVESTMENT AS ITS WHOLLY OWNED SUBSIDIARY LOVE HEMP EXPANDS PRODUCT LINE IN UK

May 14, 2020 6:00 AM

Love Hemp Immune line accelerated to market to meet growing demand

CODEBASE VENTURES INC. INVESTMENT TRAD3R MOBILE GAME APP LAUNCHES BRAND NEW PLATFORM

May 13, 2020 6:00 AM

THE NEW TRAD3R APP IS BUILT TO TRADE 1,000S OF DIFFERENT CELEBRITIES, SPORTS TEAMS, STOCKS & FRIENDS

CODEBASE VENTURES INC. UPDATES ADVANCEMENT ON HYDROXYCHLOROQUINE STRATEGY

May 11, 2020 6:00 AM

COMPANY HAS SECURED RIGHTS TO INNOVATIVE TRANSDERMAL DELIVERY FOR HYDROXYCHLOROQUINE WHICH IS ANTICIPATED TO REDUCE SIDE EFFECTS AND IMPROVE OUTCOMES

CODEBASE INVESTMENT WORLD HIGH LIFE UPDATES SALES GROWTH OF WHOLLY OWNED SUBSIDIARY LOVE HEMP IN THE UK

May 08, 2020 6:00 AM

Love Hemp online sales increase by 39% month on month during global pandemic

CODEBASE VENTURES INC. ANNOUNCES SECOND CLOSING OF FINANCING

May 05, 2020 3:25 PM

CODEBASE INVESTMENT ADDS ORAL MUCOSAL PATENT FILING, EXPANDING TRANSDERMAL TREATMENTS

April 23, 2020 12:01 AM

New US Provisional Patent Filing for Novel Oral Drug Delivery of Chloroquine and/or Hydroxychloroquine Complements Transdermal Patch for drug used globally for Malaria, Lupus and Rheumatoid Arthritis

HYDROXYCHLOROQUINE SIDE EFFECTS POTENTIALLY MITIGATED BY TRANSDERMAL DELIVERY

April 21, 2020 12:05 AM

Codebase Investee has secured rights to develop a Transdermal Hydroxychloroquine Drug Delivery System to offer controlled, prescribed dosage mitigating side effects

HYDROXYCHLOROQUINE TREATMENT FOR COVID-19 BENEFITS SOUGHT IN GLOBAL RESEARCH EFFORT TO ESTABLISH EFFICACY

April 20, 2020 6:30 AM

Codebase investee has secured rights to Transdermal Hydroxychloroquine Drug Delivery System

CODEBASE VENTURES INC. ANNOUNCES $1.5 MILLION FINANCING AND FIRST CLOSING OF FINANCING

April 16, 2020 2:30 PM

CODEBASE TO INVEST IN COMPANY DEVELOPING HYDROXYCHLOROQUINE TRANSDERMAL TREATMENT

April 16, 2020 12:01 AM